- Home
- OLOX vs MYNZ Comparison
OLOX vs MYNZ Comparison
Compare OLOX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLOX | MYNZ |
|---|---|---|
| Founded | 2007 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 5.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OLOX | MYNZ |
|---|---|---|
| Price | $1.35 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 227.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,628.82 | N/A |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.79 | $0.55 |
| 52 Week High | $2.19 | $5.34 |
Technical Indicators
Market Signals| Indicator | OLOX | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 48.07 |
| Support Level | $0.86 | $0.57 |
| Resistance Level | $2.19 | $0.94 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 40.60 | 69.44 |
Price Performance
Historical ComparisonAbout OLOX Olenox Industries Inc. Common Stock
Olenox Industries Inc is an industrial holding company focused on acquiring, operating, and scaling businesses that provide engineered solutions across industrial, energy, and infrastructure markets. Through its subsidiaries, it delivers high-quality modular and containerized systems designed for rapid deployment and long-term performance.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.